Business Context and Reporting Period
This Form 8-K filing by Minerva Neurosciences, Inc. (Delaware) reports a corporate governance event. The report date is September 6, 2017, covering the resignation of a Board member effective September 8, 2017.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the resignation of Francesco De Rubertis from the Board of Directors and the Nominating and Corporate Governance Committee. The resignation is effective September 8, 2017.
Outlook, Risks, and Management Commentary
- Reason for Departure: Dr. De Rubertis is resigning to focus on other opportunities.
- Disagreement Status: The filing explicitly states the decision did not involve any disagreement with the Company, its management, or the Board.
- Unusual Items: No unusual items, contingencies, or forward-looking guidance are disclosed in this specific filing.
Key Facts for Investor Verification
- Francesco De Rubertis resigned as a Director effective September 8, 2017.
- The resignation was voluntary and unrelated to any disputes with the Company.
- Dr. De Rubertis also stepped down from the Nominating and Corporate Governance Committee.
- The filing was signed by Geoffrey Race, Executive Vice President, Chief Financial Officer, and Chief Business Officer.